FR2143163B2 - - Google Patents

Info

Publication number
FR2143163B2
FR2143163B2 FR7222310A FR7222310A FR2143163B2 FR 2143163 B2 FR2143163 B2 FR 2143163B2 FR 7222310 A FR7222310 A FR 7222310A FR 7222310 A FR7222310 A FR 7222310A FR 2143163 B2 FR2143163 B2 FR 2143163B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7222310A
Other languages
French (fr)
Other versions
FR2143163A2 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of FR2143163A2 publication Critical patent/FR2143163A2/fr
Application granted granted Critical
Publication of FR2143163B2 publication Critical patent/FR2143163B2/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7222310A 1971-06-22 1972-06-21 Expired FR2143163B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2920771A GB1381872A (en) 1971-06-22 1971-06-22 Pharmaceutical compositions for inhalation

Publications (2)

Publication Number Publication Date
FR2143163A2 FR2143163A2 (en) 1973-02-02
FR2143163B2 true FR2143163B2 (en) 1975-10-31

Family

ID=10287853

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7222310A Expired FR2143163B2 (en) 1971-06-22 1972-06-21

Country Status (9)

Country Link
JP (1) JPS5046820A (en)
AU (1) AU462722B2 (en)
CA (1) CA970685A (en)
DE (1) DE2229981C3 (en)
DK (1) DK134970B (en)
FR (1) FR2143163B2 (en)
GB (1) GB1381872A (en)
NL (1) NL176743C (en)
ZA (1) ZA723999B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2332663C2 (en) * 1973-06-23 1986-07-31 Schering AG, 1000 Berlin und 4709 Bergkamen Use of corticosteroid active ingredients for inhalation therapy
GB1520247A (en) * 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
JPS6034925B2 (en) * 1979-07-31 1985-08-12 帝人株式会社 Long-acting nasal preparation and its manufacturing method
EP0266443B1 (en) * 1986-11-03 1993-06-23 Allen W. Jacobs Process for the inclusion of a solid particulate component into aerosol formulations of inhalable nicotine
BE891013A (en) * 1980-11-05 1982-05-05 Fisons Ltd PHARMACEUTICAL COMPOSITIONS
IT1220979B (en) * 1981-06-04 1990-06-21 Lofarma Farma Lab CAPSULES CONTAINING AN ALLERGEN AND PROCEDURE FOR THEIR PREPARATION
JPS59163313A (en) * 1983-03-09 1984-09-14 Teijin Ltd Peptide hormone composition for nasal administration
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (en) 1994-07-16 1996-01-18 Asta Medica Ag Formulation for inhalation application
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
ITMI991582A1 (en) 1999-07-16 2001-01-16 Chiesi Farma Spa DUST CONSTITUTED FROM PARTICLES HAVING THE PERFECTLY SMOOTH SURFACE FOR USE AS VEHICLES FOR THE PREPARATION OF INALA MIXTURES
US7022311B1 (en) 1999-10-12 2006-04-04 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
PE20011227A1 (en) 2000-04-17 2002-01-07 Chiesi Farma Spa PHARMACEUTICAL FORMULATIONS FOR DRY POWDER INHALERS IN THE FORM OF HARD AGGLOMERATES
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
EP1913939B1 (en) 2000-06-27 2017-05-31 Vectura Limited Formulations for use in inhaler devices
ES2689704T3 (en) 2000-11-30 2018-11-15 Vectura Limited Particles for use in a pharmaceutical composition
US8048451B2 (en) 2000-11-30 2011-11-01 Vectura Limited Pharmaceutical compositions for inhalation
TW200524577A (en) 2003-11-04 2005-08-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
MY144753A (en) 2004-04-27 2011-10-31 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
ES2613391T3 (en) 2005-02-10 2017-05-24 Glaxo Group Limited Lactose manufacturing procedures using preclassification techniques and pharmaceutical formulations formed therefrom
EP2400950B1 (en) 2009-02-26 2019-05-22 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
PL3833964T3 (en) 2018-08-07 2023-09-04 Norton (Waterford) Limited Application of raman spectroscopy for the manufacture of inhalation powders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1122284A (en) * 1965-03-19 1968-08-07 Fisons Pharmaceuticals Ltd Inhalation device
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
NL176743C (en) 1985-06-03
DE2229981C3 (en) 1981-04-02
JPS5046820A (en) 1975-04-25
DK134970C (en) 1977-07-18
NL176743B (en) 1985-01-02
DE2229981B2 (en) 1980-07-03
NL7208207A (en) 1972-12-28
CA970685A (en) 1975-07-08
AU462722B2 (en) 1975-07-03
AU4380572A (en) 1974-01-03
DE2229981A1 (en) 1972-12-28
ZA723999B (en) 1973-06-27
DK134970B (en) 1977-02-21
GB1381872A (en) 1975-01-29
FR2143163A2 (en) 1973-02-02

Similar Documents

Publication Publication Date Title
FR2143163A2 (en)
AU2658571A (en)
AU2691671A (en)
AU2684071A (en)
AU3005371A (en)
AU2485671A (en)
AU2564071A (en)
AU2742671A (en)
AU2894671A (en)
AU2941471A (en)
AU2952271A (en)
AU2486471A (en)
AU2755871A (en)
AU3025871A (en)
AU3038671A (en)
AU2940971A (en)
AU2938071A (en)
AU2930871A (en)
AU2927871A (en)
AU2907471A (en)
AU2455871A (en)
AU2885171A (en)
AU2880771A (en)
AU2875571A (en)
AU2854371A (en)